| Date Filed | Type | Description |
| 09/08/2022 |
SC 13G/A
| PRIMECAP MANAGEMENT CO reports a 0% stake in Epizyme, Inc. |
| 08/23/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 08/17/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/17/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/17/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2022 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 13,060 shares
@ $0
Disposed/sold 8,994 shares
@ $0
Disposed/sold 3,380,951 shares
@ $0 |
|
| 08/16/2022 |
4
| Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 53,324 shares
@ $0
Disposed/sold 8,994 shares
@ $0 |
|
| 08/16/2022 |
4
| Richon Victoria (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 13,614 shares
@ $0
Disposed/sold 8,994 shares
@ $0 |
|
| 08/16/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Unknown transaction of 215,494 shares
@ $0
Disposed/sold 8,994 shares
@ $0
Unknown transaction of 106,959 shares
@ $0 |
|
| 08/16/2022 |
4
| BEVERIDGE, ROY A (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 20,341 shares
@ $0
Disposed/sold 25,696 shares
@ $0 |
|
| 08/16/2022 |
4
| Agarwal Shefali (See Remarks) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 179,247 shares
@ $0
Disposed/sold 107,292 shares
@ $0 |
|
| 08/16/2022 |
4
| Korn Jerald (COO) has filed a Form 4 on Epizyme, Inc. |
| 08/16/2022 |
4
| Legorreta Pablo G. (10% Owner) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Unknown transaction of 31,933,334 shares
@ $0
Disposed/sold 8,060 restricted stock units
@ $0
Disposed/sold 8,994 restricted stock units
@ $0 |
|
| 08/16/2022 |
4
| Beaulieu Joseph (See Remarks) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 30,181 shares
@ $0
Disposed/sold 21,895 shares
@ $0 |
|
| 08/16/2022 |
4
| BATE KENNETH (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 8,060 shares
@ $0
Disposed/sold 8,994 shares
@ $0 |
|
| 08/16/2022 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 39,046 shares
@ $0
Disposed/sold 81,021 shares
@ $0 |
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2022 |
4
| Bogle Grant C. (President and CEO) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 84,170 shares
@ $0
Disposed/sold 175,000 shares
@ $0 |
|
| 08/09/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/09/2022 |
8-K
| Quarterly results |
| 08/05/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/04/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/01/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 08/01/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 07/12/2022 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 07/12/2022 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 07/07/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/05/2022 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| BEVERIDGE, ROY A (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 8,928 shares
@ $1.47, valued at
$13.1k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
SC 13D/A
| RPI Finance Trust reports a 20.6% stake in Epizyme, Inc. |
| 06/27/2022 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
|